Home
    • Plans Blog Contact
    INTEGRATED BIOPHARMA INC logo

    INTEGRATED BIOPHARMA INC

    INBP
    Last price US$0.16
    Market cap US$5.0m
    12M price change -43.02%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    General Mills IncGIS Industry peer Ingredion IncINGR Industry peer FLOWERS FOODS INCFLO Industry peer Hershey CoHSY Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    INTEGRATED BIOPHARMA INC Overview

    Industry: Packaged Foods

    Sector: Consumer Defensive

    Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for INTEGRATED BIOPHARMA INC into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 08, 2026

    Quarterly result summary

    Revenue was $10.1M (reported). Net loss was -$0.8M.

    Revenue $10.1M reported
    Net loss -$0.8M reported

    What changed

    • Revenue reported to $10.1M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing FORM 8-K May 08, 2026 SEC filing FORM 10-Q May 08, 2026 SEC filing FORM 8-K Feb 11, 2026 SEC filing FORM 10-Q Feb 11, 2026 Earnings release EXHIBIT 99.1 INBP PRESS RELEASE FEBRUARY 11 2026 Feb 11, 2026 SEC filing FORM 10-Q Nov 10, 2025 SEC filing FORM 8-K Nov 10, 2025 Earnings release EXHIBIT 99.1 INBP PRESS RELEASE NOVEMBER 10 2025 Nov 10, 2025 SEC filing FORM 8-K Sep 23, 2025 Earnings release EXHIBIT 99.1 PRESS RELEASE DATED 09 23 2025 Sep 23, 2025 SEC filing FORM 10-K Sep 23, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    No qualified company news in the last 14 days

    No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.

    Earnings Per Share

    Score 2.00/5
    INTEGRATED BIOPHARMA INC earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Hershey Co Procter & Gamble Company Grand Canyon Education Inc
    In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

    Return on Equity

    Score 1.88/5
    INTEGRATED BIOPHARMA INC exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Hershey Co Procter & Gamble Company Grand Canyon Education Inc
    INTEGRATED B... INBP US$5.0m
    Hershey Co HSY US$36.9b
    Procter & Ga... PG US$343.4b
    Grand Canyon... LOPE US$4.0b

    Net Margin

    Score 4.12/5
    INTEGRATED BIOPHARMA INC commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Hershey Co Procter & Gamble Company Grand Canyon Education Inc
    INTEGRATED B... INBP US$5.0m
    Hershey Co HSY US$36.9b
    Procter & Ga... PG US$343.4b
    Grand Canyon... LOPE US$4.0b

    Share Buyback

    In Packaged Foods industry , General Mills Inc , Ingredion Inc , FLOWERS FOODS INC are companies with high ratings.

    Leverage

    Score 3.25/5
    INTEGRATED BIOPHARMA INC attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Hershey Co Procter & Gamble Company Grand Canyon Education Inc , also exhibit high scores.
    INTEGRATED B... INBP US$5.0m
    Hershey Co HSY US$36.9b
    Procter & Ga... PG US$343.4b
    Grand Canyon... LOPE US$4.0b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    INTEGRATED BIOPHARMA INC logo

    INTEGRATED BIOPHARMA INC

    US$0.16

    US$0.924

    +477.3% vs price

    US$5.0m

    0.00%

    -43.02%